CULVER CITY, Calif. - Nov. 12, 2024 - Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, expands its network of providers with Scionti Prostate Center, a Halo Precision Diagnostics affiliate, in Sarasota, Florida. This brings AI technology to Florida’s Gulf Coast that has been proven to increase physicians’ ability to identify the extent of prostate cancer by 25%.
Unfold AI combines a patient’s prior imaging with biopsy results and pathology data to create a 3D cancer estimation map. This map predicts where the cancer is, helps determine the best course of treatment, and helps determine where tissue should be treated during an intervention. With this knowledge, physicians can better recommend tailored treatments and provide patients with informed guidance when deciding their course of treatment.
Stephen Scionti, MD, is the Director of Focal Therapy Services at Halo Precision Diagnostics and founder of the Scionti Prostate Center. He specializes in HIFU, TULSA and Cryoablation to treat prostate cancer and has received global recognition for his methods of image-guided ablation. Incorporating the increased diagnostic capabilities of FDA-cleared Unfold AI into the diagnostic process allows for greater certainty in recommending targeted treatments for appropriate cases, giving patients and providers confidence that the entirety of the cancer is treated.
“Using traditional surgical treatments, patients may still experience cancer recurrence or lifelong side effects,” said Dr. Scionti. “That’s a pretty high price for a man to pay. The powerful predictive imaging of Unfold AI unlocks the one thing we were never really sure of: just how much of the prostate needs to be treated to eradicate a dangerous tumor and how much can be preserved, because preserving prostate tissue preserves function.”
“We are very excited to see Unfold AI implemented in new regions across the country, expanding access to this life-changing AI technology,” said Shyam Natarajan, PhD and CEO of Avenda Health. “By enhancing the diagnostic capabilities of our providers, we can deliver better health outcomes for prostate cancer patients.”
For more information about Unfold AI, visit avendahealth.com.
About Avenda Health
Avenda Health is creating a more personalized future of prostate cancer care. Using deep learning, Avenda Health software maps a patient’s cancer in 3D, giving physicians precise information and the confidence to make care decisions. Dedicated to bringing this cutting-edge technology to all practices and physicians treating prostate cancer patients, Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.
Back to HCB News
